Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -975 | -307 | -491 | -387 | -591 |
| Other Investing Activity | 0 | 0 | 14 | 33,067 | -14,931 |
| Investing Cash Flow | $-975 | $-307 | $-477 | $32,680 | $-15,522 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 145,816 | 92,057 | 12,650 | N/A | 41,079 |
| Common Stock Repurchased | -6,802 | -1,569 | -976 | N/A | -2,295 |
| Other Financing Activity | -358 | -294 | -233 | -182 | -227 |
| Financing Cash Flow | $138,656 | $90,194 | $11,441 | $-182 | $38,558 |
| Exchange Rate Effect | 56 | 5 | -81 | -41 | -52 |
| Beginning Cash Position | 66,875 | 15,572 | 29,110 | 18,435 | 7,242 |
| End Cash Position | 153,050 | 66,875 | 15,572 | 29,110 | 18,435 |
| Net Cash Flow | $86,120 | $51,299 | $-13,458 | $10,716 | $11,245 |
| Free Cash Flow | |||||
| Capital Expenditure | -975 | -307 | -491 | -387 | -591 |
| Free Cash Flow | -975 | -307 | -491 | -387 | -591 |